Rationalizing the Formation of Belinostat Solvates with Experimental Screening and Computational Predictions

Zhonghua Li, Ruiling Ouyang, Peng Shi, Shichao Du, Junbo Gong, Songgu Wu

Crystal Growth & Design · 2021 · 12 citations · 34 references

Concepts

Abstract

Belinostat is a histone deacetylase inhibitor for the treatment of refractory T-cell lymphoma. Our study found that the tendency to form solvates of belinostat with hydrogen-bond acceptor type solvents was obvious based on the COSMO-RS model. Motivated by the prediction results, we investigated eight novel solvates, with 1,4-dioxane, tetrahydrofuran, furan, 3-picoline, cyclopentanone, 1-methyl-2-pyrrolidinone, and dimethyl sulfoxide/water as guest molecules, obtained by different crystallization methods. The obtained solid forms were thoroughly characterized with various analytical techniques, namely, powder X-ray diffraction, Fourier transform infrared spectroscopy, and thermal analysis. The thermal stability order of solvates was S3PC > S′Diox > SNMP > SCP > SFuran > STHF > SDiox > SDMSO/H2O, and a strong correlation between the boiling points of solvents and the crystal lattice energy with the thermal stability of solvates was observed. Additionally, six crystal structures of five solvates and the reported Form I were successfully determined from single-crystal X-ray diffraction data. The results revealed that the belinostat molecule adopted flexible conformations in different crystal structures; meanwhile, the formation of belinostat solvate was mainly driven by the belinostat–solvent intermolecular interactions and the improved packing efficiency due to the introduction of solvent molecules.

References

34